Literature DB >> 33024009

Implementation of a targeted mastitis therapy concept using an on-farm rapid test: antimicrobial consumption, cure rates and compliance.

Anne Schmenger1, Stefanie Leimbach1, Nicole Wente1, Yanchao Zhang1, Andrew Martin Biggs2, Volker Kroemker3.   

Abstract

BACKGROUND: Aim of the present study was to investigate the implementation of a targeted therapy (tLCT) concept under real-life circumstances, taking both pathogen-related and animal-related factors into account. The reduction of antibiotics without negative effects on cure rates was evaluated as well as the compliance by the farmers.
METHODS: After analysing the existing conventional therapy (CT) concepts of five farms, the tLCT concept and a novel on-farm test were introduced. Three treatment groups were compared with respect to bacteriological cure (BC), cytological cure (CYC), full cure (FC), new infection rate (NIR), relapse rate and the treatment approach per mastitis case: the CT group, the tLCT group including all clinical mastitis (CM) cases treated according to the concept, and the modified tLCT group (tLCTmod), including the CM cases in which farmers deviated from the concept.
RESULTS: Even so farmers deviated from the treatment concept in 506 out of 909 cases; belonging to one of the three treatment groups had no significant impact on BC, CYC, FC, NIR or relapse rate. The antibiotic usage in the tLCT as well as in the tLCTmod group was significantly lower in comparison to the CT group.
CONCLUSION: From this, it can be deduced that farmers will reduce antibiotic doses by implementing a tLCT concept. © British Veterinary Association 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical mastitis; on-farm culture; reducing antibiotic use; selective therapy; targeted therapy

Mesh:

Substances:

Year:  2020        PMID: 33024009     DOI: 10.1136/vr.105674

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Potential of ESBL-producing Escherichia coli selection in bovine feces after intramammary administration of first generation cephalosporins using in vitro experiments.

Authors:  David C Speksnijder; Nonke E M Hopman; Nina E Kusters; Arjen Timmerman; Jantijn M Swinkels; Pleun A A Penterman; Volker Krömker; Andrew J Bradley; Nadine Botteldoorn; Ronette Gehring; Aldert L Zomer
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

2.  Different European Perspectives on the Treatment of Clinical Mastitis in Lactation.

Authors:  Franziska Preine; Demetrio Herrera; Christian Scherpenzeel; Piret Kalmus; Finola McCoy; Sebastian Smulski; Päivi Rajala-Schultz; Anne Schmenger; Paolo Moroni; Volker Krömker
Journal:  Antibiotics (Basel)       Date:  2022-08-16

3.  Characterization, Cure Rates and Associated Risks of Clinical Mastitis in Northern Germany.

Authors:  Anne Schmenger; Volker Krömker
Journal:  Vet Sci       Date:  2020-11-03

4.  Non-inferiority Trial Investigating the Efficacy of Non-steroidal Anti-inflammatory Drugs and Antimicrobial Treatment of Mild to Moderate Clinical Mastitis in Dairy Cows With Long-lasting Udder Diseases.

Authors:  Volker Krömker; Anne Schmenger; Doris Klocke; Ellen Maria Mansion-de Vries; Nicole Wente; Yanchao Zhang; Stefanie Leimbach
Journal:  Front Vet Sci       Date:  2021-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.